 | • レポートコード：QYR2104Z0108 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、159ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、養子細胞移植療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（NK、LAK、DC、CIK、CTL、TIL、TCR-T、CAR-T）、用途別市場規模（急性リンパ性白血病、NHL、黒色腫、膀胱がん、肺がん、頭頸部がん、多発性骨髄腫、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・養子細胞移植療法の市場動向 ・企業の競争状況、市場シェア ・養子細胞移植療法の種類別市場規模（NK、LAK、DC、CIK、CTL、TIL、TCR-T、CAR-T） ・養子細胞移植療法の用途別市場規模（急性リンパ性白血病、NHL、黒色腫、膀胱がん、肺がん、頭頸部がん、多発性骨髄腫、その他） ・養子細胞移植療法の北米市場規模2016-2027（アメリカ、カナダ） ・養子細胞移植療法のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・養子細胞移植療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・養子細胞移植療法の中南米市場規模2016-2027（メキシコ、ブラジル） ・養子細胞移植療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Novartis AG、Kite Pharma、Pfizer、Juno Therapeutics、Celgene Corporation、CARsgen Therapeutics、Sorrento Therapeutics、Legend Biotech、Atara Biotherapeutics、Aurora Biopharma、Autolus Therapeutics PLC、Bluebird、Carina Biotech、Athenex、Xiangxue Pharmaceutical (Xiangxue Precision)、Hengrui Yuanzheng、Eureka Therapeutics、WuXi Juno、Shenzhen Inno Immunity、Shenzhen Binde Bio、Kerui Bio、Adaptimmune、Altor Bioscience Corporation、Cellectis、Takara Bio、Unum Therapeutics） ・結論 |
Market Analysis and Insights: Global Adoptive Cell Transfer Therapy Market
The global Adoptive Cell Transfer Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Adoptive Cell Transfer Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Adoptive Cell Transfer Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Adoptive Cell Transfer Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Adoptive Cell Transfer Therapy market.
Global Adoptive Cell Transfer Therapy Scope and Market Size
Adoptive Cell Transfer Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Adoptive Cell Transfer Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
NK
LAK
DC
CIK
CTL
TIL
TCR-T
CAR-T
Segment by Application
Acute Lymphocytic Leukemia
NHL
Melanoma
Bladder Cancer
Lung Cancer
Head and Neck Cancer
Multiple Myeloma
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Novartis AG
Kite Pharma
Pfizer
Juno Therapeutics
Celgene Corporation
CARsgen Therapeutics
Sorrento Therapeutics
Legend Biotech
Atara Biotherapeutics
Aurora Biopharma
Autolus Therapeutics PLC
Bluebird
Carina Biotech
Athenex
Xiangxue Pharmaceutical (Xiangxue Precision)
Hengrui Yuanzheng
Eureka Therapeutics
WuXi Juno
Shenzhen Inno Immunity
Shenzhen Binde Bio
Kerui Bio
Adaptimmune
Altor Bioscience Corporation
Cellectis
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adoptive Cell Transfer Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 NK
1.2.3 LAK
1.2.4 DC
1.2.5 CIK
1.2.6 CTL
1.2.7 TIL
1.2.8 TCR-T
1.2.9 CAR-T
1.3 Market by Application
1.3.1 Global Adoptive Cell Transfer Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Acute Lymphocytic Leukemia
1.3.3 NHL
1.3.4 Melanoma
1.3.5 Bladder Cancer
1.3.6 Lung Cancer
1.3.7 Head and Neck Cancer
1.3.8 Multiple Myeloma
1.3.9 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Adoptive Cell Transfer Therapy Market Perspective (2016-2027)
2.2 Adoptive Cell Transfer Therapy Growth Trends by Regions
2.2.1 Adoptive Cell Transfer Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Adoptive Cell Transfer Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Adoptive Cell Transfer Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Adoptive Cell Transfer Therapy Industry Dynamic
2.3.1 Adoptive Cell Transfer Therapy Market Trends
2.3.2 Adoptive Cell Transfer Therapy Market Drivers
2.3.3 Adoptive Cell Transfer Therapy Market Challenges
2.3.4 Adoptive Cell Transfer Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Adoptive Cell Transfer Therapy Players by Revenue
3.1.1 Global Top Adoptive Cell Transfer Therapy Players by Revenue (2016-2021)
3.1.2 Global Adoptive Cell Transfer Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Adoptive Cell Transfer Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Adoptive Cell Transfer Therapy Revenue
3.4 Global Adoptive Cell Transfer Therapy Market Concentration Ratio
3.4.1 Global Adoptive Cell Transfer Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adoptive Cell Transfer Therapy Revenue in 2020
3.5 Adoptive Cell Transfer Therapy Key Players Head office and Area Served
3.6 Key Players Adoptive Cell Transfer Therapy Product Solution and Service
3.7 Date of Enter into Adoptive Cell Transfer Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Adoptive Cell Transfer Therapy Breakdown Data by Type
4.1 Global Adoptive Cell Transfer Therapy Historic Market Size by Type (2016-2021)
4.2 Global Adoptive Cell Transfer Therapy Forecasted Market Size by Type (2022-2027)
5 Adoptive Cell Transfer Therapy Breakdown Data by Application
5.1 Global Adoptive Cell Transfer Therapy Historic Market Size by Application (2016-2021)
5.2 Global Adoptive Cell Transfer Therapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Adoptive Cell Transfer Therapy Market Size (2016-2027)
6.2 North America Adoptive Cell Transfer Therapy Market Size by Type
6.2.1 North America Adoptive Cell Transfer Therapy Market Size by Type (2016-2021)
6.2.2 North America Adoptive Cell Transfer Therapy Market Size by Type (2022-2027)
6.2.3 North America Adoptive Cell Transfer Therapy Market Size by Type (2016-2027)
6.3 North America Adoptive Cell Transfer Therapy Market Size by Application
6.3.1 North America Adoptive Cell Transfer Therapy Market Size by Application (2016-2021)
6.3.2 North America Adoptive Cell Transfer Therapy Market Size by Application (2022-2027)
6.3.3 North America Adoptive Cell Transfer Therapy Market Size by Application (2016-2027)
6.4 North America Adoptive Cell Transfer Therapy Market Size by Country
6.4.1 North America Adoptive Cell Transfer Therapy Market Size by Country (2016-2021)
6.4.2 North America Adoptive Cell Transfer Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Adoptive Cell Transfer Therapy Market Size (2016-2027)
7.2 Europe Adoptive Cell Transfer Therapy Market Size by Type
7.2.1 Europe Adoptive Cell Transfer Therapy Market Size by Type (2016-2021)
7.2.2 Europe Adoptive Cell Transfer Therapy Market Size by Type (2022-2027)
7.2.3 Europe Adoptive Cell Transfer Therapy Market Size by Type (2016-2027)
7.3 Europe Adoptive Cell Transfer Therapy Market Size by Application
7.3.1 Europe Adoptive Cell Transfer Therapy Market Size by Application (2016-2021)
7.3.2 Europe Adoptive Cell Transfer Therapy Market Size by Application (2022-2027)
7.3.3 Europe Adoptive Cell Transfer Therapy Market Size by Application (2016-2027)
7.4 Europe Adoptive Cell Transfer Therapy Market Size by Country
7.4.1 Europe Adoptive Cell Transfer Therapy Market Size by Country (2016-2021)
7.4.2 Europe Adoptive Cell Transfer Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Adoptive Cell Transfer Therapy Market Size (2016-2027)
8.2 Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Type
8.2.1 Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Application
8.3.1 Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Region
8.4.1 Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Adoptive Cell Transfer Therapy Market Size (2016-2027)
9.2 Latin America Adoptive Cell Transfer Therapy Market Size by Type
9.2.1 Latin America Adoptive Cell Transfer Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Adoptive Cell Transfer Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Adoptive Cell Transfer Therapy Market Size by Type (2016-2027)
9.3 Latin America Adoptive Cell Transfer Therapy Market Size by Application
9.3.1 Latin America Adoptive Cell Transfer Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Adoptive Cell Transfer Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Adoptive Cell Transfer Therapy Market Size by Application (2016-2027)
9.4 Latin America Adoptive Cell Transfer Therapy Market Size by Country
9.4.1 Latin America Adoptive Cell Transfer Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Adoptive Cell Transfer Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Adoptive Cell Transfer Therapy Market Size (2016-2027)
10.2 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Type
10.2.1 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Application
10.3.1 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Country
10.4.1 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Adoptive Cell Transfer Therapy Introduction
11.1.4 Novartis AG Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.1.5 Novartis AG Recent Development
11.2 Kite Pharma
11.2.1 Kite Pharma Company Details
11.2.2 Kite Pharma Business Overview
11.2.3 Kite Pharma Adoptive Cell Transfer Therapy Introduction
11.2.4 Kite Pharma Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.2.5 Kite Pharma Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Adoptive Cell Transfer Therapy Introduction
11.3.4 Pfizer Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Juno Therapeutics
11.4.1 Juno Therapeutics Company Details
11.4.2 Juno Therapeutics Business Overview
11.4.3 Juno Therapeutics Adoptive Cell Transfer Therapy Introduction
11.4.4 Juno Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.4.5 Juno Therapeutics Recent Development
11.5 Celgene Corporation
11.5.1 Celgene Corporation Company Details
11.5.2 Celgene Corporation Business Overview
11.5.3 Celgene Corporation Adoptive Cell Transfer Therapy Introduction
11.5.4 Celgene Corporation Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.5.5 Celgene Corporation Recent Development
11.6 CARsgen Therapeutics
11.6.1 CARsgen Therapeutics Company Details
11.6.2 CARsgen Therapeutics Business Overview
11.6.3 CARsgen Therapeutics Adoptive Cell Transfer Therapy Introduction
11.6.4 CARsgen Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.6.5 CARsgen Therapeutics Recent Development
11.7 Sorrento Therapeutics
11.7.1 Sorrento Therapeutics Company Details
11.7.2 Sorrento Therapeutics Business Overview
11.7.3 Sorrento Therapeutics Adoptive Cell Transfer Therapy Introduction
11.7.4 Sorrento Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.7.5 Sorrento Therapeutics Recent Development
11.8 Legend Biotech
11.8.1 Legend Biotech Company Details
11.8.2 Legend Biotech Business Overview
11.8.3 Legend Biotech Adoptive Cell Transfer Therapy Introduction
11.8.4 Legend Biotech Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.8.5 Legend Biotech Recent Development
11.9 Atara Biotherapeutics
11.9.1 Atara Biotherapeutics Company Details
11.9.2 Atara Biotherapeutics Business Overview
11.9.3 Atara Biotherapeutics Adoptive Cell Transfer Therapy Introduction
11.9.4 Atara Biotherapeutics Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.9.5 Atara Biotherapeutics Recent Development
11.10 Aurora Biopharma
11.10.1 Aurora Biopharma Company Details
11.10.2 Aurora Biopharma Business Overview
11.10.3 Aurora Biopharma Adoptive Cell Transfer Therapy Introduction
11.10.4 Aurora Biopharma Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.10.5 Aurora Biopharma Recent Development
11.11 Autolus Therapeutics PLC
11.11.1 Autolus Therapeutics PLC Company Details
11.11.2 Autolus Therapeutics PLC Business Overview
11.11.3 Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Introduction
11.11.4 Autolus Therapeutics PLC Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.11.5 Autolus Therapeutics PLC Recent Development
11.12 Bluebird
11.12.1 Bluebird Company Details
11.12.2 Bluebird Business Overview
11.12.3 Bluebird Adoptive Cell Transfer Therapy Introduction
11.12.4 Bluebird Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.12.5 Bluebird Recent Development
11.13 Carina Biotech
11.13.1 Carina Biotech Company Details
11.13.2 Carina Biotech Business Overview
11.13.3 Carina Biotech Adoptive Cell Transfer Therapy Introduction
11.13.4 Carina Biotech Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.13.5 Carina Biotech Recent Development
11.14 Athenex
11.14.1 Athenex Company Details
11.14.2 Athenex Business Overview
11.14.3 Athenex Adoptive Cell Transfer Therapy Introduction
11.14.4 Athenex Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.14.5 Athenex Recent Development
11.15 Xiangxue Pharmaceutical (Xiangxue Precision)
11.15.1 Xiangxue Pharmaceutical (Xiangxue Precision) Company Details
11.15.2 Xiangxue Pharmaceutical (Xiangxue Precision) Business Overview
11.15.3 Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Introduction
11.15.4 Xiangxue Pharmaceutical (Xiangxue Precision) Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.15.5 Xiangxue Pharmaceutical (Xiangxue Precision) Recent Development
11.16 Hengrui Yuanzheng
11.16.1 Hengrui Yuanzheng Company Details
11.16.2 Hengrui Yuanzheng Business Overview
11.16.3 Hengrui Yuanzheng Adoptive Cell Transfer Therapy Introduction
11.16.4 Hengrui Yuanzheng Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.16.5 Hengrui Yuanzheng Recent Development
11.17 Eureka Therapeutics
11.17.1 Eureka Therapeutics Company Details
11.17.2 Eureka Therapeutics Business Overview
11.17.3 Eureka Therapeutics Adoptive Cell Transfer Therapy Introduction
11.17.4 Eureka Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.17.5 Eureka Therapeutics Recent Development
11.18 WuXi Juno
11.18.1 WuXi Juno Company Details
11.18.2 WuXi Juno Business Overview
11.18.3 WuXi Juno Adoptive Cell Transfer Therapy Introduction
11.18.4 WuXi Juno Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.18.5 WuXi Juno Recent Development
11.18 Shenzhen Inno Immunity
11.25.1 Shenzhen Inno Immunity Company Details
11.25.2 Shenzhen Inno Immunity Business Overview
11.25.3 Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Introduction
11.25.4 Shenzhen Inno Immunity Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.25.5 Shenzhen Inno Immunity Recent Development
11.20 Shenzhen Binde Bio
11.20.1 Shenzhen Binde Bio Company Details
11.20.2 Shenzhen Binde Bio Business Overview
11.20.3 Shenzhen Binde Bio Adoptive Cell Transfer Therapy Introduction
11.20.4 Shenzhen Binde Bio Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.20.5 Shenzhen Binde Bio Recent Development
11.21 Kerui Bio
11.21.1 Kerui Bio Company Details
11.21.2 Kerui Bio Business Overview
11.21.3 Kerui Bio Adoptive Cell Transfer Therapy Introduction
11.21.4 Kerui Bio Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.21.5 Kerui Bio Recent Development
11.22 Adaptimmune
11.22.1 Adaptimmune Company Details
11.22.2 Adaptimmune Business Overview
11.22.3 Adaptimmune Adoptive Cell Transfer Therapy Introduction
11.22.4 Adaptimmune Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.22.5 Adaptimmune Recent Development
11.23 Altor Bioscience Corporation
11.23.1 Altor Bioscience Corporation Company Details
11.23.2 Altor Bioscience Corporation Business Overview
11.23.3 Altor Bioscience Corporation Adoptive Cell Transfer Therapy Introduction
11.23.4 Altor Bioscience Corporation Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.23.5 Altor Bioscience Corporation Recent Development
11.24 Cellectis
11.24.1 Cellectis Company Details
11.24.2 Cellectis Business Overview
11.24.3 Cellectis Adoptive Cell Transfer Therapy Introduction
11.24.4 Cellectis Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.24.5 Cellectis Recent Development
11.25 Takara Bio
11.25.1 Takara Bio Company Details
11.25.2 Takara Bio Business Overview
11.25.3 Takara Bio Adoptive Cell Transfer Therapy Introduction
11.25.4 Takara Bio Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.25.5 Takara Bio Recent Development
11.26 Unum Therapeutics
11.26.1 Unum Therapeutics Company Details
11.26.2 Unum Therapeutics Business Overview
11.26.3 Unum Therapeutics Adoptive Cell Transfer Therapy Introduction
11.26.4 Unum Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.26.5 Unum Therapeutics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Adoptive Cell Transfer Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of NK
Table 3. Key Players of LAK
Table 4. Key Players of DC
Table 5. Key Players of CIK
Table 6. Key Players of CTL
Table 7. Key Players of TIL
Table 8. Key Players of TCR-T
Table 9. Key Players of CAR-T
Table 10. Global Adoptive Cell Transfer Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Adoptive Cell Transfer Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Adoptive Cell Transfer Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 13. Global Adoptive Cell Transfer Therapy Market Share by Regions (2016-2021)
Table 14. Global Adoptive Cell Transfer Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 15. Global Adoptive Cell Transfer Therapy Market Share by Regions (2022-2027)
Table 16. Adoptive Cell Transfer Therapy Market Trends
Table 17. Adoptive Cell Transfer Therapy Market Drivers
Table 18. Adoptive Cell Transfer Therapy Market Challenges
Table 19. Adoptive Cell Transfer Therapy Market Restraints
Table 20. Global Adoptive Cell Transfer Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 21. Global Adoptive Cell Transfer Therapy Market Share by Players (2016-2021)
Table 22. Global Top Adoptive Cell Transfer Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adoptive Cell Transfer Therapy as of 2020)
Table 23. Ranking of Global Top Adoptive Cell Transfer Therapy Companies by Revenue (US$ Million) in 2020
Table 24. Global 5 Largest Players Market Share by Adoptive Cell Transfer Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Adoptive Cell Transfer Therapy Product Solution and Service
Table 27. Date of Enter into Adoptive Cell Transfer Therapy Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Adoptive Cell Transfer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 30. Global Adoptive Cell Transfer Therapy Revenue Market Share by Type (2016-2021)
Table 31. Global Adoptive Cell Transfer Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 32. Global Adoptive Cell Transfer Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 33. Global Adoptive Cell Transfer Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 34. Global Adoptive Cell Transfer Therapy Revenue Market Share by Application (2016-2021)
Table 35. Global Adoptive Cell Transfer Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 36. Global Adoptive Cell Transfer Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 37. North America Adoptive Cell Transfer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 38. North America Adoptive Cell Transfer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 39. North America Adoptive Cell Transfer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 40. North America Adoptive Cell Transfer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 41. North America Adoptive Cell Transfer Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 42. North America Adoptive Cell Transfer Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 43. Europe Adoptive Cell Transfer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 44. Europe Adoptive Cell Transfer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 45. Europe Adoptive Cell Transfer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 46. Europe Adoptive Cell Transfer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 47. Europe Adoptive Cell Transfer Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 48. Europe Adoptive Cell Transfer Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 50. Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 52. Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 54. Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 55. Latin America Adoptive Cell Transfer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 56. Latin America Adoptive Cell Transfer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 57. Latin America Adoptive Cell Transfer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 58. Latin America Adoptive Cell Transfer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 59. Latin America Adoptive Cell Transfer Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 60. Latin America Adoptive Cell Transfer Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 62. Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 64. Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 66. Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 67. Novartis AG Company Details
Table 68. Novartis AG Business Overview
Table 69. Novartis AG Adoptive Cell Transfer Therapy Product
Table 70. Novartis AG Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 71. Novartis AG Recent Development
Table 72. Kite Pharma Company Details
Table 73. Kite Pharma Business Overview
Table 74. Kite Pharma Adoptive Cell Transfer Therapy Product
Table 75. Kite Pharma Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 76. Kite Pharma Recent Development
Table 77. Pfizer Company Details
Table 78. Pfizer Business Overview
Table 79. Pfizer Adoptive Cell Transfer Therapy Product
Table 80. Pfizer Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 81. Pfizer Recent Development
Table 82. Juno Therapeutics Company Details
Table 83. Juno Therapeutics Business Overview
Table 84. Juno Therapeutics Adoptive Cell Transfer Therapy Product
Table 85. Juno Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 86. Juno Therapeutics Recent Development
Table 87. Celgene Corporation Company Details
Table 88. Celgene Corporation Business Overview
Table 89. Celgene Corporation Adoptive Cell Transfer Therapy Product
Table 90. Celgene Corporation Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 91. Celgene Corporation Recent Development
Table 92. CARsgen Therapeutics Company Details
Table 93. CARsgen Therapeutics Business Overview
Table 94. CARsgen Therapeutics Adoptive Cell Transfer Therapy Product
Table 95. CARsgen Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 96. CARsgen Therapeutics Recent Development
Table 97. Sorrento Therapeutics Company Details
Table 98. Sorrento Therapeutics Business Overview
Table 99. Sorrento Therapeutics Adoptive Cell Transfer Therapy Product
Table 100. Sorrento Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 101. Sorrento Therapeutics Recent Development
Table 102. Legend Biotech Company Details
Table 103. Legend Biotech Business Overview
Table 104. Legend Biotech Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 105. Legend Biotech Recent Development
Table 106. Atara Biotherapeutics Company Details
Table 107. Atara Biotherapeutics Business Overview
Table 108. Atara Biotherapeutics Adoptive Cell Transfer Therapy Product
Table 109. Atara Biotherapeutics Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 110. Atara Biotherapeutics Recent Development
Table 111. Aurora Biopharma Company Details
Table 112. Aurora Biopharma Business Overview
Table 113. Aurora Biopharma Adoptive Cell Transfer Therapy Product
Table 114. Aurora Biopharma Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 115. Aurora Biopharma Recent Development
Table 116. Autolus Therapeutics PLC Company Details
Table 117. Autolus Therapeutics PLC Business Overview
Table 118. Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Product
Table 119. Autolus Therapeutics PLC Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 120. Autolus Therapeutics PLC Recent Development
Table 121. Bluebird Company Details
Table 122. Bluebird Business Overview
Table 123. Bluebird Adoptive Cell Transfer Therapy Product
Table 124. Bluebird Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 125. Bluebird Recent Development
Table 126. Carina Biotech Company Details
Table 127. Carina Biotech Business Overview
Table 128. Carina Biotech Adoptive Cell Transfer Therapy Product
Table 129. Carina Biotech Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 130. Carina Biotech Recent Development
Table 131. Athenex Company Details
Table 132. Athenex Business Overview
Table 133. Athenex Adoptive Cell Transfer Therapy Product
Table 134. Athenex Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 135. Athenex Recent Development
Table 136. Xiangxue Pharmaceutical (Xiangxue Precision) Company Details
Table 137. Xiangxue Pharmaceutical (Xiangxue Precision) Business Overview
Table 138. Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Product
Table 139. Xiangxue Pharmaceutical (Xiangxue Precision) Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 140. Xiangxue Pharmaceutical (Xiangxue Precision) Recent Development
Table 141. Hengrui Yuanzheng Company Details
Table 142. Hengrui Yuanzheng Business Overview
Table 143. Hengrui Yuanzheng Adoptive Cell Transfer Therapy Product
Table 144. Hengrui Yuanzheng Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 145. Hengrui Yuanzheng Recent Development
Table 146. Eureka Therapeutics Company Details
Table 147. Eureka Therapeutics Business Overview
Table 148. Eureka Therapeutics Adoptive Cell Transfer Therapy Product
Table 149. Eureka Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 150. Eureka Therapeutics Recent Development
Table 151. WuXi Juno Company Details
Table 152. WuXi Juno Business Overview
Table 153. WuXi Juno Adoptive Cell Transfer Therapy Product
Table 154. WuXi Juno Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 155. WuXi Juno Recent Development
Table 156. Shenzhen Inno Immunity Company Details
Table 157. Shenzhen Inno Immunity Business Overview
Table 158. Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Product
Table 159. Shenzhen Inno Immunity Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 160. Shenzhen Inno Immunity Recent Development
Table 161. Shenzhen Binde Bio Company Details
Table 162. Shenzhen Binde Bio Business Overview
Table 163. Shenzhen Binde Bio Adoptive Cell Transfer Therapy Product
Table 164. Shenzhen Binde Bio Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 165. Shenzhen Binde Bio Recent Development
Table 166. Kerui Bio Company Details
Table 167. Kerui Bio Business Overview
Table 168. Kerui Bio Adoptive Cell Transfer Therapy Product
Table 169. Kerui Bio Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 170. Kerui Bio Recent Development
Table 171. Adaptimmune Company Details
Table 172. Adaptimmune Business Overview
Table 173. Adaptimmune Adoptive Cell Transfer Therapy Product
Table 174. Adaptimmune Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 175. Adaptimmune Recent Development
Table 176. Altor Bioscience Corporation Company Details
Table 177. Altor Bioscience Corporation Business Overview
Table 178. Altor Bioscience Corporation Adoptive Cell Transfer Therapy Product
Table 179. Altor Bioscience Corporation Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 180. Altor Bioscience Corporation Recent Development
Table 181. Cellectis Company Details
Table 182. Cellectis Business Overview
Table 183. Cellectis Adoptive Cell Transfer TherapyProduct
Table 184. Cellectis Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 185. Cellectis Recent Development
Table 186. Takara Bio Company Details
Table 187. Takara Bio Business Overview
Table 188. Takara Bio Adoptive Cell Transfer Therapy Product
Table 189. Takara Bio Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 190. Takara Bio Recent Development
Table 191. Unum Therapeutics Company Details
Table 192. Unum Therapeutics Business Overview
Table 193. Unum Therapeutics Adoptive Cell Transfer Therapy Product
Table 194. Unum Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 195. Unum Therapeutics Recent Development
Table 196. Research Programs/Design for This Report
Table 197. Key Data Information from Secondary Sources
Table 198. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Adoptive Cell Transfer Therapy Market Share by Type: 2020 VS 2027
Figure 2. NK Features
Figure 3. LAK Features
Figure 4. DC Features
Figure 5. CIK Features
Figure 6. CTL Features
Figure 7. TIL Features
Figure 8. TCR-T Features
Figure 9. CAR-T Features
Figure 10. Global Adoptive Cell Transfer Therapy Market Share by Application: 2020 VS 2027
Figure 11. Acute Lymphocytic Leukemia Case Studies
Figure 12. NHL Case Studies
Figure 13. Melanoma Case Studies
Figure 14. Bladder Cancer Case Studies
Figure 15. Lung Cancer Case Studies
Figure 16. Head and Neck Cancer Case Studies
Figure 17. Multiple Myeloma Case Studies
Figure 18. Other Case Studies
Figure 19. Adoptive Cell Transfer Therapy Report Years Considered
Figure 20. Global Adoptive Cell Transfer Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 21. Global Adoptive Cell Transfer Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 22. Global Adoptive Cell Transfer Therapy Market Share by Regions: 2020 VS 2027
Figure 23. Global Adoptive Cell Transfer Therapy Market Share by Regions (2022-2027)
Figure 24. Global Adoptive Cell Transfer Therapy Market Share by Players in 2020
Figure 25. Global Top Adoptive Cell Transfer Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adoptive Cell Transfer Therapy as of 2020
Figure 26. The Top 10 and 5 Players Market Share by Adoptive Cell Transfer Therapy Revenue in 2020
Figure 27. Global Adoptive Cell Transfer Therapy Revenue Market Share by Type (2016-2021)
Figure 28. Global Adoptive Cell Transfer Therapy Revenue Market Share by Type (2022-2027)
Figure 29. North America Adoptive Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. North America Adoptive Cell Transfer Therapy Market Share by Type (2016-2027)
Figure 31. North America Adoptive Cell Transfer Therapy Market Share by Application (2016-2027)
Figure 32. North America Adoptive Cell Transfer Therapy Market Share by Country (2016-2027)
Figure 33. United States Adoptive Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Canada Adoptive Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Europe Adoptive Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Europe Adoptive Cell Transfer Therapy Market Share by Type (2016-2027)
Figure 37. Europe Adoptive Cell Transfer Therapy Market Share by Application (2016-2027)
Figure 38. Europe Adoptive Cell Transfer Therapy Market Share by Country (2016-2027)
Figure 39. Germany Adoptive Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. France Adoptive Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. U.K. Adoptive Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Italy Adoptive Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Russia Adoptive Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Nordic Adoptive Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Asia-Pacific Adoptive Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Asia-Pacific Adoptive Cell Transfer Therapy Market Share by Type (2016-2027)
Figure 47. Asia-Pacific Adoptive Cell Transfer Therapy Market Share by Application (2016-2027)
Figure 48. Asia-Pacific Adoptive Cell Transfer Therapy Market Share by Region (2016-2027)
Figure 49. China Adoptive Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Japan Adoptive Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. South Korea Adoptive Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Southeast Asia Adoptive Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. India Adoptive Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Australia Adoptive Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Latin America Adoptive Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Latin America Adoptive Cell Transfer Therapy Market Share by Type (2016-2027)
Figure 57. Latin America Adoptive Cell Transfer Therapy Market Share by Application (2016-2027)
Figure 58. Latin America Adoptive Cell Transfer Therapy Market Share by Country (2016-2027)
Figure 59. Mexico Adoptive Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Brazil Adoptive Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Middle East & Africa Adoptive Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Middle East & Africa Adoptive Cell Transfer Therapy Market Share by Type (2016-2027)
Figure 63. Middle East & Africa Adoptive Cell Transfer Therapy Market Share by Application (2016-2027)
Figure 64. Middle East & Africa Adoptive Cell Transfer Therapy Market Share by Country (2016-2027)
Figure 65. Turkey Adoptive Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 66. Saudi Arabia Adoptive Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 67. UAE Adoptive Cell Transfer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 68. Novartis AG Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2016-2021)
Figure 69. Kite Pharma Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2016-2021)
Figure 70. Pfizer Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2016-2021)
Figure 71. Juno Therapeutics Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2016-2021)
Figure 72. Celgene Corporation Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2016-2021)
Figure 73. CARsgen Therapeutics Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2016-2021)
Figure 74. Sorrento Therapeutics Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2016-2021)
Figure 75. Legend Biotech Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2016-2021)
Figure 76. Atara Biotherapeutics Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2016-2021)
Figure 77. Aurora Biopharma Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2016-2021)
Figure 78. Autolus Therapeutics PLC Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2016-2021)
Figure 79. Bluebird Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2016-2021)
Figure 80. Carina Biotech Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2016-2021)
Figure 81. Athenex Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2016-2021)
Figure 82. Xiangxue Pharmaceutical (Xiangxue Precision) Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2016-2021)
Figure 83. Hengrui Yuanzheng Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2016-2021)
Figure 84. Eureka Therapeutics Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2016-2021)
Figure 85. WuXi Juno Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2016-2021)
Figure 86. Shenzhen Inno Immunity Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2016-2021)
Figure 87. Shenzhen Binde Bio Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2016-2021)
Figure 88. Kerui Bio Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2016-2021)
Figure 89. Adaptimmune Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2016-2021)
Figure 90. Altor Bioscience Corporation Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2016-2021)
Figure 91. Cellectis Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2016-2021)
Figure 92. Takara Bio Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2016-2021)
Figure 93. Unum Therapeutics Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2016-2021)
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed
世界の養子細胞療法（ACT）市場規模・現状・予測（2021年-2027年） Adoptive cell therapy, also known as cellular immunotherapy, is a form of treatment that uses the cells of our immune system to eliminate cancer. Market Analysis and Insights: Global Adoptive Cell Therapy Market The global Adoptive Cell Therapy market size is projected to reach US$ XX million by 202…- 世界のがん幹細胞（CSC）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cancer Stem Cell Therapy Market The global Cancer Stem Cell Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the …
- 世界のT細胞移植療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global T Cell Transfer Therapy Market The global T Cell Transfer Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the re…
- 世界の小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small Cell Lung Cancer Treatment Market The global Small Cell Lung Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data…
- 世界の小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small Cell Lung Cancer Treatment Market The global Small Cell Lung Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data…